These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21068576)

  • 1. Comment on the impact of gene patents and licensing practices on access to genetic testing: lessons from hereditary hemorrhagic telangiectasia.
    Messner DA; Pyeritz RE; Bernhardt BA
    Genet Med; 2010 Nov; 12(11):746-8. PubMed ID: 21068576
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis.
    Chandrasekharan S; Pitlick E; Heaney C; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S155-70. PubMed ID: 20393306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis.
    Chandrasekharan S; Heaney C; James T; Conover C; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S194-211. PubMed ID: 20393308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia.
    Bernhardt BA; Zayac C; Pyeritz RE
    Genet Med; 2011 Sep; 13(9):812-20. PubMed ID: 21637104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene patents and licensing: case studies prepared for the Secretary's Advisory Committee on Genetics, Health, and Society.
    Cook-Deegan R; Heaney C
    Genet Med; 2010 Apr; 12(4 Suppl):S1-2. PubMed ID: 20393303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do patents impede the provision of genetic tests in Australia?
    Nicol D; Liddicoat J
    Aust Health Rev; 2013 Jun; 37(3):281-5. PubMed ID: 23702081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of gene patents and licensing practices on access to genetic testing for hearing loss.
    Chandrasekharan S; Fiffer M
    Genet Med; 2010 Apr; 12(4 Suppl):S171-93. PubMed ID: 20393307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians.
    Bayrak-Toydemir P; Mao R; Lewin S; McDonald J
    Genet Med; 2004; 6(4):175-91. PubMed ID: 15266205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global health licensing program: a new model for humanitarian licensing at the university level.
    Roose-Snyder B; Doyle MK
    Am J Law Med; 2009; 35(2-3):281-309. PubMed ID: 19697750
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient information. Hereditary hemorrhagic telangiectasia.
    Am Fam Physician; 2010 Oct; 82(7):797-8. PubMed ID: 20879702
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of gene patents and licensing practices on access to genetic testing for long QT syndrome.
    Angrist M; Chandrasekharan S; Heaney C; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S111-54. PubMed ID: 20393304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal and hepatic manifestations of hereditary hemorrhagic telangiectasia.
    Sharma VK; Howden CW
    Dig Dis; 1998; 16(3):169-74. PubMed ID: 9618136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary Hemorrhagic Telangiectasia Management.
    Peterson J
    Radiol Technol; 2017 Jan; 88(3):277-294. PubMed ID: 28298578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurovascular screening in hereditary haemorrhagic telangiectasia: dilemmas for the paediatric neuroscience community.
    Ganesan V; Robertson F; Berg J
    Dev Med Child Neurol; 2013 May; 55(5):405-7. PubMed ID: 23020298
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of gene patents on diagnostic testing: a new patent landscaping method applied to spinocerebellar ataxia.
    Berthels N; Matthijs G; Van Overwalle G
    Eur J Hum Genet; 2011 Nov; 19(11):1114-21. PubMed ID: 21811306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Legal Vacuum Surrounding Access to Gene-based Research Materials and Data.
    Nicol D
    J Law Med; 2016; 24(1):72-88. PubMed ID: 30136775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compulsory licensing to regulated licensing: effects on the conflict between innovation and access in the pharmaceutical industry.
    Gillat A
    Food Drug Law J; 2003; 58(4):711-40. PubMed ID: 15027457
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastrointestinal lesions in hereditary hemorrhagic telangiectasia.
    Vase P; Grove O
    Gastroenterology; 1986 Nov; 91(5):1079-83. PubMed ID: 3489651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis.
    McDonald J; Bayrak-Toydemir P; Pyeritz RE
    Genet Med; 2011 Jul; 13(7):607-16. PubMed ID: 21546842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey confirms fears about licensing of genetic tests.
    Schissel A; Merz JF; Cho MK
    Nature; 1999 Nov; 402(6758):118. PubMed ID: 10646997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.